OptimizeRx Corporation (OPRX) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $6.68 (+7.22%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 6, 2026 | David Grossman | Stifel Nicolaus | $17.00 | +154.5% |
| Apr 4, 2024 | Constantine Davides | JMP Securities | $15.00 | +124.6% |
Top Analysts Covering OPRX
OPRX vs Sector & Market
| Metric | OPRX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.29 | 2.24 | 2.41 |
| Analyst Count | 7 | 8 | 18 |
| Target Upside | +154.5% | +1150.1% | +14.9% |
| P/E Ratio | 25.63 | 6.84 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $23M | $25M | $27M | 5 |
| 2026-09-30 | $27M | $30M | $32M | 2 |
| 2026-12-31 | $34M | $38M | $40M | 2 |
| 2027-03-31 | $17M | $19M | $21M | 2 |
| 2027-06-30 | $24M | $27M | $29M | 2 |
| 2027-09-30 | $28M | $32M | $34M | 2 |
| 2027-12-31 | $36M | $40M | $43M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.11 | $0.16 | $0.19 | 4 |
| 2026-09-30 | $0.23 | $0.27 | $0.29 | 1 |
| 2026-12-31 | $0.43 | $0.50 | $0.55 | 2 |
| 2027-03-31 | $0.02 | $0.03 | $0.03 | 2 |
| 2027-06-30 | $0.16 | $0.18 | $0.20 | 1 |
| 2027-09-30 | $0.26 | $0.31 | $0.33 | 1 |
| 2027-12-31 | $0.48 | $0.56 | $0.61 | 2 |
Frequently Asked Questions
What is the analyst consensus for OPRX?
The consensus among 7 analysts covering OptimizeRx Corporation (OPRX) is Buy with an average price target of $20.00.
What is the highest price target for OPRX?
The highest price target for OPRX is $17.00, set by David Grossman at Stifel Nicolaus on 2026-03-06.
What is the lowest price target for OPRX?
The lowest price target for OPRX is $15.00, set by Constantine Davides at JMP Securities on 2024-04-04.
How many analysts cover OPRX?
7 analysts have issued ratings for OptimizeRx Corporation in the past 12 months.
Is OPRX a buy or sell right now?
Based on 7 analyst ratings, OPRX has a consensus rating of Buy (2.29/5) with a +154.5% upside to the consensus target of $20.00.
What are the earnings estimates for OPRX?
Analysts estimate OPRX will report EPS of $0.16 for the period ending 2026-06-30, with revenue estimated at $25M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.